EQS-Adhoc
Evonik Industries AG: Evonik publishes preliminary figures for the first quarter of 2024
- Evonik Industries AG reports Q1 2024 adjusted EBITDA of €522 million, exceeding expectations.
- Sales for Q1 2024 amounted to €3.796 billion, lower due to declining prices.
- Evonik expects adjusted EBITDA between €1.7 billion and €2.0 billion for 2024.
EQS-Ad-hoc: Evonik Industries AG / Key word(s): Preliminary Results/Quarter Results Evonik publishes preliminary figures for the first quarter of 2024 |
Essen, April 16, 2024. Evonik Industries AG publishes the following preliminary key financial figures for the first quarter of 2024 already today.
Based on preliminary figures, Evonik achieved an adjusted EBITDA* of just under €522 million in the first quarter of 2024 (Q1 2023: €409 million), thus well above market expectations (analyst consensus disclosed by Vara Research on March 26, 2024: around €450 million). The Specialty Additives and Nutrition & Care divisions recorded the strongest growth. The upturn was driven by higher sales volumes: Following seven quarters of declines, volumes were above the previous year's level. In addition to a slight upturn in end customer demand, restocking in light of low inventory levels at customers also contributed to the higher volumes.
According to preliminary figures, Evonik’s sales amounted to €3.796 billion in the first quarter of 2024, compared with €4.0 billion in the prior-year quarter. This was mainly due to declining sales prices as a result of lower raw material costs. Consensus expected this number to be approximately €3.883 billion.
Evonik continues to expect adjusted EBITDA* of between €1.7 billion and €2.0 billion and sales of between €15 billion and €17 billion.
Evonik Industries AG will publish final figures and the quarterly report for the first quarter 2024 as planned on May 8, 2024.
*Notes on key performance indicators (KPIs) can be found in the Financial Report 2023 of Evonik Industries AG starting on page 240.
The Financial Report 2023 is available at:
https://files.evonik.com/shared-files/evonik-financial-report-2023-949 ...
Contact/person making the notification:
Tim Lange
Head of Investor Relations
+49 201 177-3150
tim.lange@evonik.com
End of Inside Information
16-Apr-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: | English |
Company: | Evonik Industries AG |
Rellinghauser Straße 1-11 | |
45128 Essen | |
Germany | |
Phone: | +49 (0) 201 177-01 |
Fax: | +49 (0) 201 177-3475 |
E-mail: | investor-relations@evonik.com |
Internet: | www.evonik.com |
ISIN: | DE000EVNK013 |
WKN: | EVNK01 |
Indices: | MDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Luxembourg Stock Exchange |
EQS News ID: | 1881517 |
End of Announcement | EQS News Service |
|
1881517 16-Apr-2024 CET/CEST